Blockade of oral tolerance to ovalbumin in mice by silver nanoparticles

Nanomedicine

Volumn 10, Issue 3, 2015, Pages 419-431

  Xu, Yingying ^a   Tang, Huan ^a   Wang, Haifang ^b   Liu, Yuanfang ^a,b  

^a PEKING UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

gastrointestinal tract; oral tolerance; ovalbumin; silver nanoparticles

Indexed keywords

OVALBUMIN; POVIDONE; SILVER; SILVER NANOPARTICLE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIGESTION; DRUG TOLERANCE; FEEDING; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REPEATED DRUG DOSE; SURFACE PROPERTY; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; FEMALE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; NANOPARTICLES; OVALBUMIN; SILVER;

EID: 84923544046     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.111     Document Type: Article

References (32)

1. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28(11), 580-588 (2010
2. Benn TM, Westerhoff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 42(11), 4133-4139 (2008
3. Chaudhry Q, Scotter M, Blackburn J., et al. Applications and implications of nanotechnologies for the food sector. Food Addit. Contam. Part A 25(3), 241-258 (2008
4. Park E-J, Bae E, Yi J., et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 30(2), 162-168 (2010
5. Kim YS, Song MY, Park JD., et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7, 20-30 (2010
6. Loeschner K, Hadrup N, Qvortrup K., et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8, 18-31 (2011
7. van der Zande M, Vandebriel RJ, Doren EV., et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6(8), 7427-7442 (2012
8. Garside P, Mowat A, Khoruts A. Oral tolerance in diseases. Gut 44(1), 137-142 (1999
9. Faria AMC, Weiner HL. Oral tolerance. Immunol. Rev. 206, 232-259 (2005
10. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3(4), 331-341 (2003
11. Khramova DS, Popov SV, Golovchenko VV, Vityazev FV, Paderin NM, Ovodov YS. Abrogation of the oral tolerance to in mice by citrus pectin. Nutrition 25(2), 226-232 (2009
12. Yoshino S, Ohsawa M, Sagai M. Diesel exhaust particles block induction of oral tolerance in mice. J. Pharmacol. Exp. Ther. 287(2), 679-683 (1998
13. Matsumura M, Takasu N, Nagata M, Nakamura K, Kawai M, Yoshino S. Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice. J. Immunotoxicol. 7(3), 232-237 (2010
14. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 22(16), 4548-4554 (2010
15. Navarro E, Piccapietra F, Wagner B., et al. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 42(23), 8959-8964 (2008
16. Cheng Y, Yin L, Lin S, Wiesner M, Bernhardt E, Liu J. Toxicity reduction of polymer-stabilized silver nanoparticles by sunlight. J. Phys. Chem. C 115(11), 4425-4432 (2011
17. Kennedy AJ, Hull MS, Bednar AJ., et al. Fractionating nanosilver: importance for determining toxicity to aquatic test organisms. Environ. Sci. Technol. 44(24), 9571-9577 (2010
18. Oliveira FM, Santos EM, Mota-Santos TA, Ruiz-De- Souza V, Gontijo CM. Covalent coupling of palmitate to inhibits and blocks the induction of oral tolerance. Scand. J. Immunol. 55(6), 570-576 (2002
19. Chen X-X, Cheng B, Yang Y-X., et al. Characterization and preliminary toxicity assay of nano-Titanium dioxide additive in sugar-coated chewing gum. Small 9(9-10), 1765-1774 (2013
20. Xu YY, Tang H, Liu J-H, Wang HF, Liu YF. Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. Toxicol. Lett. 219(1), 42-48 (2013
21. Li BW, Rush A, Zhang SR, Curtis KC, Weil GJ. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filarial J. 3, 1-8 (2004
22. Kim T, Lee CH, Joo SW, Lee K. Kinetics of gold nanoparticle aggregation: experiments and modeling. J. Colloid. Interface Sci. 318(2), 238-243 (2008
23. Xiu Z-M, Zhang QB, Puppala HL, Colvin VL, Alvarez PJJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett. 12(8), 4271-4275 (2012
24. Böhmert L, Niemann B, Thünemann AF, Lampen A. Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2. Arch. Toxicol. 86(7), 1107-1115 (2012
25. Hadrup N, Lam HR, Loeschner K, Mortensen A, Larsen EH, Frandsen H. Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics. J. Appl. Toxicol. 32(11), 929-933 (2012
26. Walczak AP, Fokkink R, Peters R., et al. Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model. Nanotoxicology 7(7), 1198-1210 (2013
27. Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41(7), 2780-2799 (2012
28. Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 106(8), 935-937 (2000
29. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28(9), 2780-2790 (1998
30. Slavin AJ, Maron R, Weiner HL. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 13(6), 825-833 (2001
31. Khoury SJ, Lider O, Al-Sabbagh A, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lypopolysaccharide. Cell. Immunol. 131(2), 302-310 (1990
32. Yang E-J, Kim S, Kim JS, Choi I-H. Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials 33(28), 6858-6867 (2012